Concord Technology Co., Ltd.

[Tianjin China (Mainland) ]

  • 7th
Business Type:
Manufacturer
Year Established:
1996
Total Revenue:
US$1 Million - US$2.5 Million
Main Markets:

Company Description

About Concord

Established in 1996, Concord Technology (Tianjin) Co., Ltd. is a manufacturer specialized in the R&D and production of high purity chemical reagents and pharmaceutical intermediates.

We are located in Tianjin, a city of 13 million populations, with port and convenient transportation access. In 2003, we built the new factory and the R&D center, covering 25000 square meters, having 6 production lines and over a hundred of varieties of products. The main products include HPLC solvents, HPLC gradient grade solvents, Pesticide Analysis grade solvents, Coulometric Karl Fischer Reagents and Volumetric Karl Fischer Reagents. The annual output of HPLC solvents is 1500 tons in 2011. We will have two large production lines next year to further improve the production capacity to 6000 tons per year. In order to supply the best products and services, we have excellent teams which focus on product research and quality control. We have obtained GB/T19001-2008/ ISO9001:2008 Quality Management System Certificates. All of our products comply with international quality standards.

We have won some prizes. We got Silver Prize for Science and Technology Progress in Tianjin (Hebei District) in 1998. Two of our products were entitled as Science and Technology Products of Tianjin. By jointly carrying out the Key Projects in the National Science & Technology Support Plan in the 11th Five-year Plan Period since 2007, we have undertaken systematic research for three years on the preparation of high purity organic solvents and the common key technology for industrialization. We have been named as Excellent Private Science & Technology Enterprise many times because of applying for 28 items of national patents and 4 items of science and technology achievements until 2012. We were responsible for drafting the HPLC methanol and HPLC Acetonitrile national industry standards, which is according to our enterprise standards. Those two standards were approved to be national chemical reagent standards by Chemical Reagent Branch Commission of National Standardization Technical Administration in 2012.

We have a professional R&D team to research and produce pharmaceutical intermediates including series of boric acids, derivatives compounds, pyridine compounds, heterocyclic compounds, benzene compounds, chiral compounds and some other compounds which are for the treatment of hepatitis C, hepatitis B drug, anti-infective drugs, and diabetes and so on.

If you are interested in any of our products or would like to have a further discuss with us, please do not hesitate to make contact with us. We are looking forward to establishing successful business relationships with new clients around the world in the near future.